![Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano](https://www.mdpi.com/vaccines/vaccines-10-01924/article_deploy/html/images/vaccines-10-01924-g001.png)
Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano
![Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant | Communications Medicine Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant | Communications Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43856-022-00141-4/MediaObjects/43856_2022_141_Fig1_HTML.png)
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant | Communications Medicine
![Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine](https://www.thelancet.com/cms/asset/dd1d2ce4-5ebe-4811-a76c-1615a5e47ad7/gr1.jpg)
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine
![Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/91d19b8e-2f0b-4e13-8d9b-69e012d37e25/gr1.jpg)